XenoHelix was founded on a nucleic acid extraction and detection platform,
and is advancing both precision molecular diagnostics and innovative biomaterials for skincare.
As a bio-venture driven by “profitable R&D”, we deliver high value to our customers, shareholders, and team members.

  • 01

    XenoHelix is a specialist in nucleic acid extraction and detection.

    We have secured technologies for the extraction and detection of not only DNA and RNA, but also miRNA.

    With nucleic acid extraction technology as our platform, we have developed capabilities that can expand into various fields, including precision diagnostics and skincare.

  • 02

    XenoHelix is growing as a highly profitable bio-venture.

    Alongside precision diagnostics R&D, we have generated revenue through our research reagent business based on our core technologies.

    We are driving efficient R&D through active participation in national research projects.

  • 03

    XenoHelix has expanded beyond precision molecular diagnostics into advanced skincare technologies.

    We are developing precision diagnostic products for metabolic dysfunction-associated fatty liver disease (MASLD) and Parkinson’s disease.

    By developing differentiated skincare materials, we have entered both domestic and global beauty markets.